A shocking decision has been made regarding newborn vaccinations, and it's causing quite a stir in the medical community. The US CDC vaccine panel has voted to end the recommendation for the hepatitis B vaccine for babies, and experts are speaking out.
Dr. Ben Kasstan-Dabush, an Assistant Professor in Global Health, provides valuable insight. He explains that routine immunization schedules are often updated, and this isn't necessarily a cause for alarm. In fact, England recently made changes to its schedule in July 2025, removing the combined Hib-MenC vaccine. But here's where it gets controversial: the U.S. situation is unique due to a recent overhaul of the Advisory Committee on Immunization Practices (ACIP).
All ACIP members were replaced, and the new committee includes individuals who are critical of vaccines. Dr. Kasstan-Dabush worries that this decision on hepatitis B vaccination is just the beginning of a strategy to erode public trust in vaccinations. He questions the independence and evidence-based nature of this move, given the committee's composition.
And this is the part most people miss: while vaccine recommendations may evolve, the process should be guided by scientific evidence and independent experts. The current circumstances raise concerns about the potential impact on public health and the future of vaccination policies.
What do you think? Is this a justified decision or a cause for concern? Share your thoughts below, and let's discuss the implications of this controversial move.
